Uncover key drivers, emerging technologies, and competitive movements shaping the endometriosis market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Endometriosis Market between 2026 and 2030?
The endometriosis market has demonstrated robust expansion in recent years. This market is set to expand from $1.54 billion in 2025 to $1.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. The primary drivers for this historical growth include the prevalent underdiagnosis of endometriosis, an increase in gynecological consultations, the rising incidence of infertility cases, the widespread adoption of hormonal therapy, and the continuous demand for effective pain management solutions.
The endometriosis market is anticipated to show robust expansion in the upcoming years, projected to reach $2.44 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.8%. This expansion during the forecast period is fueled by factors such as early screening efforts, enhanced diagnostic precision, individualized treatment strategies, initiatives promoting women’s health, and the proliferation of specialty care services. Significant trends expected in the forecast period encompass an increasing understanding of chronic pelvic pain, a rise in the identification of fertility-related conditions, the broader adoption of hormonal treatments, the growth of specialized gynecology centers, and an emphasis on ongoing disease management.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Endometriosis Market?
The rising incidence of ovarian cancer is projected to stimulate the expansion of the endometriosis market in the future. Ovarian cancer is a malignancy that originates in the ovaries, which are female reproductive organs responsible for the production of eggs and the hormones estrogen and progesterone. Endometriosis is associated with an elevated risk of developing epithelial ovarian cancer, specifically the endometrioid and precise cell cancer subtypes, characterized by high estrogen concentrations, which can heighten the chances of developing ovarian cancer. For instance, in January 2023, data from the American Cancer Society, a US-based professional organization, indicated a projection of approximately 19,710 new cases of ovarian cancer to be diagnosed among women in the US in 2023. Furthermore, in 2022, according to the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, ovarian cancer was responsible for 12,810 deaths in 2022, with this figure increasing to 13,270 fatalities in 2023. Therefore, the growing occurrence of ovarian cancer is serving as a driver for the endometriosis market’s growth.
What Segments Are Included Within The Endometriosis Market?
The endometriosis market covered in this report is segmented –
1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types
2) By Treatment Type: Hormonal Therapy, Pain Management
3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs
4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Superficial Peritoneal Lesion: Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions
2) By Endometrioma: Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma
3) By Deeply Infiltrating Endometriosis: Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions
4) By Other Types: Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis
Which Market Trends Are Opening Growth Opportunities In The Endometriosis Market?
Major companies in the endometriosis market are actively developing inventive solutions, including non-invasive diagnostic assays, to enhance early detection and patient management. Non-invasive diagnostic assays are examinations designed to identify or monitor a disease without requiring surgery or the insertion of instruments into the body, often utilizing blood, urine, saliva, or imaging. For instance, in July 2025, Kephera Diagnostics LLC, a US-based diagnostic laboratory, introduced EndomTest, an innovative blood-based diagnostic test for endometriosis. EndomTest is a laboratory-developed test that analyzes a patient’s serum sample for the biomarkers Brain-Derived Neurotrophic Factor (BDNF) and Cancer Antigen 125 (CA125), subsequently combining these biomarker results with selected clinical variables using a proprietary diagnostic algorithm to generate a positive or negative “rule-in” indication for endometriosis. Its distinguishing attributes include a non-surgical sampling method (simply a blood draw), high specificity (reported at nearly 100%) for identifying the condition, and clinical applications spanning women presenting with pelvic pain, heavy menstrual bleeding, infertility, or pain with sexual intercourse.
Who Are The Primary Competitors In The Global Endometriosis Market?
Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report
Which Regions Are Projected To Dominate The Endometriosis Market In The Coming Years?
North America was the largest region in the endometriosis market in 2025. The regions covered in the endometriosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Endometriosis Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp
Browse Through More Reports Similar to the Global Endometriosis Market 2026, By The Business Research Company
Uterine Fibroids Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report
Endometrial Cancer Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/endometrial-cancer-treatment-global-market-report
Endometrial Ablation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/endometrial-ablation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model